Issue Date: September 11, 2017 | Web Date: September 6, 2017
Germany’s Merck eyes consumer products exit
Today’s pharmaceutical companies have a love-hate relationship with the over-the-counter drug business. OTC drugs are steady sellers that don’t require a lot of risky R&D. But they don’t bring high profits either.
Germany’s Merck KGaA has decided it isn’t fond of the OTC business and is exploring options to leave the field. The firm says it doesn’t have the scale to compete in OTC drugs and that they don’t fit anymore with its focus on . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society